Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  osteoporosis
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-14 of 14 for your search:
Start Over
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068781, U10CA031946, CALGB-79809, NCI-P01-0184, NCT00022087
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069502, NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N02C1, NCI-2012-02515, CDR0000270449, N02C1, NCT00054418
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000413877, NCCTG-N03CC, N03CC, NCT00107263
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0518, CDR0000476469, NCI-2009-00884, 0518, NCT00329797
Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Closed
Age: Premenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000637437, IBCSG-25A-02, BIG-25A-02, NABCI-IBCSG-25A-02, NCT00963417
Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: MA27B, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, CDR0000483099, NCIC-MA.27B, NCT00354302
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000067078, P30CA011198, URCC-U2898, NCI-G99-1522, NCT00003903
Ancillary Study of Bone Density in Premenopausal Women with Breast Cancer Treated on Protocol EST-5188 (Summary Last Modified 11/91)
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: premenopausal
Sponsor: NCI
Protocol IDs: EST-C-0290, SWOG-9054, NCI-P91-0004
Randomized Pilot Study of Letrozole With Versus Without Zoledronate in Healthy Postmenopausal Women With High Breast Density
Phase: No phase specified
Type: Prevention, Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UVACC-HIC-11019, UVACC-31003, NCT00114270
Zoledronate in Treating Osteopenia or Osteoporosis in Postmenopausal Women Receiving Letrozole for Stage I, Stage II, or Stage IIIA Primary Breast Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: MC05C8, P30CA015083, 2330-05, MCCRC-MC05C8, MCCRC-IRB-2330-05, NCT00436917
Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 35 to 50
Sponsor: NCI, Other
Protocol IDs: NU 95B2, NCI-G00-1737, NCT00005605
Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast Cancer
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000069229, OHSU-6312, NCI-H02-0086, NCT00031811
Start Over